BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28061796)

  • 41. The effects of GLUT1 on the survival of head and neck squamous cell carcinoma.
    Li S; Yang X; Wang P; Ran X
    Cell Physiol Biochem; 2013; 32(3):624-34. PubMed ID: 24022001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells.
    Sobhakumari A; Orcutt KP; Love-Homan L; Kowalski CE; Parsons AD; Knudson CM; Simons AL
    Oncol Res; 2016; 24(1):55-64. PubMed ID: 27178822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD73 is associated with poor prognosis in HNSCC.
    Ren ZH; Lin CZ; Cao W; Yang R; Lu W; Liu ZQ; Chen YM; Yang X; Tian Z; Wang LZ; Li J; Wang X; Chen WT; Ji T; Zhang CP
    Oncotarget; 2016 Sep; 7(38):61690-61702. PubMed ID: 27557512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of Tiam 1 on cell proliferation and migration in head and neck squamous cell carcinoma cells].
    Xiao P; Fu Q; Li Z; Zhang X; Fu X; Wan R
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Apr; 29(7):633-7. PubMed ID: 26201191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.
    Yamada Y; Koshizuka K; Hanazawa T; Kikkawa N; Okato A; Idichi T; Arai T; Sugawara S; Katada K; Okamoto Y; Seki N
    Int J Oncol; 2018 Jan; 52(1):166-178. PubMed ID: 29115582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling.
    Yang S; Ji Q; Chang B; Wang Y; Zhu Y; Li D; Huang C; Wang Y; Sun G; Zhang L; Guan Q; Xiang J; Wei W; Lu Z; Liao T; Meng J; Wang Z; Ma B; Zhou L; Wang Y; Yang G
    Oncotarget; 2017 Jan; 8(4):5976-5991. PubMed ID: 27863406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway.
    Shimizu S; Tsukada J; Sugimoto T; Kikkawa N; Sasaki K; Chazono H; Hanazawa T; Okamoto Y; Seki N
    Int J Cancer; 2008 Oct; 123(8):1816-23. PubMed ID: 18661521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis
    Hsu JY; Chang JY; Chang KY; Chang WC; Chen BK
    FASEB J; 2017 Oct; 31(10):4265-4276. PubMed ID: 28596235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
    Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
    Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma.
    Van Tubergen E; Vander Broek R; Lee J; Wolf G; Carey T; Bradford C; Prince M; Kirkwood KL; D'Silva NJ
    Cancer; 2011 Jun; 117(12):2677-89. PubMed ID: 21656745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Down-regulation of neutrophil gelatinase-associated lipocalin in head and neck squamous cell carcinoma correlated with tumorigenesis, not with metastasis.
    Wang L; Chen C; Li F; Hua Q; Chen S; Xiao B; Dai M; Li M; Zheng A; Yu D; Hu Z; Tao Z
    Int J Clin Exp Pathol; 2015; 8(8):8857-68. PubMed ID: 26464627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance.
    Suh YE; Raulf N; Gäken J; Lawler K; Urbano TG; Bullenkamp J; Gobeil S; Huot J; Odell E; Tavassoli M
    Int J Cancer; 2015 Sep; 137(5):1021-34. PubMed ID: 25523631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
    Wu F; Wu LL; Zhu LX
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
    [No Abstract]   [Full Text] [Related]  

  • 55. Therapeutic Targeting of BRD4 in Head Neck Squamous Cell Carcinoma.
    Wu Y; Wang Y; Diao P; Zhang W; Li J; Ge H; Song Y; Li Z; Wang D; Liu L; Jiang H; Cheng J
    Theranostics; 2019; 9(6):1777-1793. PubMed ID: 31037138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.
    Cao W; Feng Z; Cui Z; Zhang C; Sun Z; Mao L; Chen W
    Cancer; 2012 Jun; 118(11):2858-71. PubMed ID: 21989926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
    Weaver AN; Burch MB; Cooper TS; Della Manna DL; Wei S; Ojesina AI; Rosenthal EL; Yang ES
    Mol Cancer Res; 2016 Sep; 14(9):883-91. PubMed ID: 27353029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative metabolic analysis in head and neck cancer and the normal gingiva.
    Voelxen NF; Blatt S; Knopf P; Henkel M; Appelhans C; Righesso LAR; Pabst A; Goldschmitt J; Walenta S; Neff A; Mueller-Klieser W; Ziebart T
    Clin Oral Investig; 2018 Mar; 22(2):1033-1043. PubMed ID: 28735466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of miRNA in head and neck squamous cell carcinoma.
    Masood Y; Kqueen CY; Rajadurai P
    Expert Rev Anticancer Ther; 2015 Feb; 15(2):183-97. PubMed ID: 25367254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma.
    Zhang XY; Li M; Sun K; Chen XJ; Meng J; Wu L; Zhang P; Tong X; Jiang WW
    Oncotarget; 2015 Jan; 6(1):101-15. PubMed ID: 25575809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.